Merck Kgaa (MRK.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -47,000 | -109,000 | -221,000 | -73,000 | -84,500 |
| Other Working Capital | -408,000 | -266,000 | -1,324,000 | -612,000 | -429,600 |
| Other Operating Activity | 3,311,000 | 2,594,000 | 4,241,000 | 3,203,000 | 2,709,300 |
| Operating Cash Flow | $2,856,000 | $2,219,000 | $2,696,000 | $2,518,000 | $2,195,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -782,000 | -879,000 | -875,000 | -695,000 | -505,000 |
| Net Acquisitions | -5,130,000 | 3,129,000 | 150,000 | 213,000 | -13,396,300 |
| Purchase Of Investment | -196,000 | -75,000 | -219,000 | -347,000 | -1,740,800 |
| Sale Of Investment | 140,000 | 55,000 | 185,000 | 457,000 | 3,858,000 |
| Purchase Sale Intangibles | -185,000 | -39,000 | -388,000 | -130,000 | -151,700 |
| Other Investing Activity | 23,000 | 67,000 | 4,000 | 1,000 | 27,400 |
| Investing Cash Flow | $-6,153,000 | $2,191,000 | $-1,147,000 | $-503,000 | $-11,935,800 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 411,000 | N/A | N/A | N/A | N/A |
| Debt Issued | 3,888,000 | 407,000 | 496,000 | 1,117,000 | 10,422,800 |
| Debt Repayment | -1,708,000 | -642,000 | -1,246,000 | -1,001,000 | -2,221,300 |
| Dividend Paid | -162,000 | -755,000 | -621,000 | -597,000 | -564,200 |
| Other Financing Activity | -527,000 | -1,835,000 | -499,000 | -1,427,000 | -473,500 |
| Financing Cash Flow | $1,902,000 | $-2,825,000 | $-1,870,000 | $-1,908,000 | $7,163,800 |
| Exchange Rate Effect | 5,000 | -5,000 | -30,000 | 8,000 | 530,500 |
| Beginning Cash Position | 2,170,000 | 589,000 | 939,000 | 832,000 | 2,878,500 |
| End Cash Position | 781,000 | 2,170,000 | 589,000 | 939,000 | 832,200 |
| Net Cash Flow | $-1,395,000 | $1,585,000 | $-321,000 | $107,000 | $-2,576,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,856,000 | 2,219,000 | 2,696,000 | 2,518,000 | 2,195,200 |
| Capital Expenditure | -1,021,000 | -1,016,000 | -1,311,000 | -848,000 | -693,000 |
| Free Cash Flow | 1,835,000 | 1,203,000 | 1,385,000 | 1,670,000 | 1,502,200 |